Free Trial

Wellington Management Group LLP Purchases New Position in Afya Limited (NASDAQ:AFYA)

Afya logo with Consumer Discretionary background

Wellington Management Group LLP bought a new stake in shares of Afya Limited (NASDAQ:AFYA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 52,203 shares of the company's stock, valued at approximately $829,000. Wellington Management Group LLP owned about 0.06% of Afya at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of AFYA. State Street Corp lifted its holdings in shares of Afya by 118.2% during the 3rd quarter. State Street Corp now owns 73,098 shares of the company's stock worth $1,248,000 after acquiring an additional 39,592 shares during the last quarter. Public Employees Retirement System of Ohio bought a new stake in Afya during the third quarter worth about $34,000. Lifestyle Asset Management Inc. raised its holdings in shares of Afya by 5.5% during the 4th quarter. Lifestyle Asset Management Inc. now owns 17,682 shares of the company's stock valued at $281,000 after buying an additional 929 shares in the last quarter. Blue Trust Inc. lifted its position in Afya by 296.9% in the 4th quarter. Blue Trust Inc. now owns 2,072 shares of the company's stock worth $35,000 after buying an additional 1,550 shares during the last quarter. Finally, Van ECK Associates Corp grew its position in Afya by 41.9% during the fourth quarter. Van ECK Associates Corp now owns 9,677 shares of the company's stock valued at $154,000 after acquiring an additional 2,856 shares during the last quarter. Hedge funds and other institutional investors own 88.02% of the company's stock.

Wall Street Analyst Weigh In

AFYA has been the subject of a number of recent research reports. Citigroup restated a "sell" rating and issued a $15.00 price objective (down from $18.00) on shares of Afya in a report on Friday, January 31st. JPMorgan Chase & Co. cut their price target on shares of Afya from $25.00 to $20.50 and set a "neutral" rating for the company in a research report on Friday, January 17th. Finally, Morgan Stanley cut Afya from an "equal weight" rating to an "underweight" rating and reduced their price objective for the company from $19.00 to $17.00 in a research note on Tuesday, March 11th. Three equities research analysts have rated the stock with a sell rating and two have assigned a hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Reduce" and a consensus target price of $17.60.

Read Our Latest Analysis on AFYA

Afya Trading Up 1.2 %

Shares of NASDAQ AFYA traded up $0.22 during trading hours on Friday, hitting $18.20. The company's stock had a trading volume of 67,158 shares, compared to its average volume of 120,845. Afya Limited has a 12 month low of $14.52 and a 12 month high of $20.06. The stock has a market cap of $1.71 billion, a price-to-earnings ratio of 14.68, a P/E/G ratio of 0.29 and a beta of 0.66. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. The business has a 50-day simple moving average of $17.44 and a 200-day simple moving average of $16.67.

Afya Dividend Announcement

The firm also recently announced a -- dividend, which was paid on Friday, April 4th. Stockholders of record on Wednesday, March 26th were paid a dividend of $0.232 per share. The ex-dividend date of this dividend was Wednesday, March 26th. Afya's dividend payout ratio (DPR) is presently 17.69%.

Afya Profile

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

See Also

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines